We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+0.57%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$186M
AUM Growth
-$8.04M
Cap. Flow
-$6.37M
Cap. Flow %
-3.42%
Top 10 Hldgs %
39.56%
Holding
107
New
1
Increased
19
Reduced
52
Closed
9

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$3.72M
2
ZTS icon
Zoetis
ZTS
+$484K
3
KVUE icon
Kenvue
KVUE
+$429K
4
TRP icon
TC Energy
TRP
+$378K
5
BWA icon
BorgWarner
BWA
+$346K

Top Sells

Rank Stock Value
1
LDOS icon
Leidos
LDOS
+$6.24M
2
AAPL icon
Apple
AAPL
+$593K
3
BA icon
Boeing
BA
+$385K
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$384K
5
BCE icon
BCE
BCE
+$358K

Sector Composition

Rank Sector Weight
1 Technology 20.36%
2 Industrials 16.58%
3 Healthcare 16.56%
4 Financials 14.68%
5 Communication Services 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWA icon
26
BorgWarner
BWA
$13.2B
$2.6M 1.4%
80,735
+9,990
+14% +$346K
MLM icon
27
Martin Marietta Materials
MLM
$33.6B
$2.39M 1.29%
4,415
-330
-7% -$192K
BMY icon
28
Bristol-Myers Squibb
BMY
$127B
$2.37M 1.28%
57,151
-1,530
-3% -$68.5K
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$121B
$2.36M 1.27%
5,041
-94
-2% -$40.8K
V icon
30
Visa
V
$677B
$2.33M 1.25%
8,862
-141
-2% -$38.6K
QCOM icon
31
Qualcomm
QCOM
$176B
$2.24M 1.21%
11,257
VGR
32
DELISTED
Vector Group Ltd.
VGR
$2.24M 1.2%
211,880
-9,950
-4% -$105K
LMT icon
33
Lockheed Martin
LMT
$134B
$2.16M 1.16%
4,630
-225
-5% -$104K
AMZN icon
34
Amazon
AMZN
$2.5T
$2.07M 1.11%
10,723
+78
+0.7% +$14.3K
TRP icon
35
TC Energy
TRP
$73.5B
$2.05M 1.1%
54,077
+9,960
+23% +$378K
CI icon
36
Cigna
CI
$76.6B
$1.99M 1.07%
6,030
-31
-0.5% -$10.7K
BAM icon
37
Brookfield Asset Management
BAM
$74B
$1.9M 1.02%
49,844
-779
-2% -$30.6K
CVS icon
38
CVS Health
CVS
$137B
$1.59M 0.86%
26,950
-1,315
-5% -$82.3K
J icon
39
Jacobs Solutions
J
$15.9B
$1.59M 0.85%
13,751
-1,191
-8% -$140K
MRK icon
40
Merck
MRK
$324B
$1.48M 0.79%
11,929
+2
+0% +$258
ZTS icon
41
Zoetis
ZTS
$31.6B
$1.47M 0.79%
8,452
+2,910
+53% +$484K
META icon
42
Meta Platforms (Facebook)
META
$1.51T
$1.42M 0.76%
2,820
+225
+9% +$109K
STZ icon
43
Constellation Brands
STZ
$22.2B
$1.36M 0.73%
5,283
-125
-2% -$32.1K
CARR icon
44
Carrier Global
CARR
$57.2B
$1.21M 0.65%
19,106
-74
-0.4% -$4.54K
ORCL icon
45
Oracle
ORCL
$331B
$1.19M 0.64%
8,441
-640
-7% -$79.5K
JNJ icon
46
Johnson & Johnson
JNJ
$635B
$1.19M 0.64%
8,143
+301
+4% +$44.8K
COO icon
47
Cooper Companies
COO
$13.7B
$1.18M 0.63%
13,489
+49
+0.4% +$4.57K
MRNA icon
48
Moderna
MRNA
$21.5B
$1.17M 0.63%
9,842
-655
-6% -$82.9K
NVDA icon
49
NVIDIA
NVDA
$5.01T
$1.13M 0.61%
9,170
+170
+2% +$17.2K
KVUE icon
50
Kenvue
KVUE
$37B
$1.11M 0.6%
61,053
+22,120
+57% +$429K

Similar funds

Lipe & Dalton's Q2 2024 Portfolio in Review

As of Q2 2024, Lipe & Dalton held 107 positions worth $186M, down 4.1% from $194M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Lipe & Dalton withdrew a net $6.37M in Q2 2024, closing 9 positions and reducing 52 holdings. Its most notable exit was Leidos, an estimated $6.24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lipe & Dalton opened a new position in The Mosaic Company worth $3.57M.

  • Lipe & Dalton's largest Q2 2024 buy was The Mosaic Company: 123,585 shares worth $3.57M.
  • Lipe & Dalton added most to Zoetis in Q2 2024, an estimated $484K increase.
  • Lipe & Dalton's biggest Q2 2024 reduction was Apple, cutting an estimated $593K.
  • Lipe & Dalton fully exited Leidos in Q2 2024, selling an estimated $6.24M.
  • Lipe & Dalton's ten largest holdings make up 40% of its $186M portfolio in Q2 2024.
  • Lipe & Dalton opened 1 new position and closed 9 in Q2 2024.
  • Lipe & Dalton's portfolio value fell 4.1% quarter-over-quarter to $186M.

Based on Lipe & Dalton's 13F filing for Q2 2024, filed 2 Aug 2024.